Citigroup Inc Zoetis Inc. Call Options Transaction History

Citigroup Inc

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 10, 2022	SELL	$148.29 - $182.55 $2.22 Million - $2.74 Million	-15,000 Reduced 75.0%	5,000 $741,000
Q1 2022 May 12, 2022	SELL	$181.39 - $234.03 $5.26 Million - $6.79 Million	-29,000 Reduced 59.18%	20,000 $3.77 Million
Q3 2021 Nov 10, 2021	BUY	$189.29 - $209.69 $9.28 Million - $10.3 Million	49,000 New	49,000 $9.51 Million

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.